Head-to-Head

Eli Lilly & Co. vs. Tonix Pharmaceuticals Holding Corp.

LLY

Eli Lilly & Co.

$1143.12 +0.02%

VS TNXP

Tonix Pharmaceuticals Holding Corp.

$8.07 -9.43%

Eli Lilly & Co. (LLY) comes out ahead, leading on 6 of 8 compared factors.

Size & Scale

LLYTNXP
Market Cap $1.02 trillion $138.41 million
Revenue (TTM) $79.67 billion $29.10 million
Net Income (TTM) $26.71 billion $-159,666,000

LLY leads on 3 of 3 size & scale factors.

Valuation

LLYTNXP
P/E Ratio 38.37 —
Price / Book 30.08 0.62
Price / Sales 12.79 4.76

TNXP leads on 2 of 2 valuation factors.

Profitability

LLYTNXP
Net Margin 33.53% -548.64%
Return on Equity 78.84% -71.83%

LLY leads on 2 of 2 profitability factors.

Dividend

LLYTNXP
Dividend Yield 0.61% —
Payout Ratio 23.23 —

LLY and TNXP split the dividend factors evenly.

Risk & Sentiment

LLYTNXP
Short Interest 1.29% 1.64%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: LLY overview, LLY financials, TNXP overview, TNXP financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.